Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region

Anticancer Research

Volumn 26, Issue 6 B, 2006, Pages 4079-4092

  White, Martyn K ^a   Skowronska, Anna ^a   Gordon, Jennifer ^a   Del Valle, Luis ^a   Deshmane, Satish L ^a   Giordano, Antonio ^b   Khalili, Kamel ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Temple University   (United States)

Author keywords

JC virus; Medulloblastoma; Neurooncogenesis; p53; T antigen

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; VIRUS T ANTIGEN;

APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; JC VIRUS; MEDULLOBLASTOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; JC VIRUS; MEDULLOBLASTOMA; MICE; MICE, TRANSGENIC; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33845923106     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Khalili K, Gordon J and White MK: The polyomavirus, JCV, and its involvement in human disease. Adv Exp Med Biol 577: 274-287, 2006.
2. White MK and Khalili K: Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 324: 1-16, 2004.
3. White MK, Gordon J, Reiss K, Del Valle L, Croul S, Giordano A, Darbinyan A and Khalili K: Human polyomaviruses and brain tumors. Brain Res Brain Res Rev 50: 69-85, 2005.
4. White MK and Khalili K: Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer 41: 2537-2548, 2005.
5. Kim JY, Koralnik IJ, LeFave M, Segal RA, Pfister LA and Pomeroy SL: Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neurooncol 4: 165-170, 2002.
6. Rollison DE, Utaipat U, Ryschkewitsch C, Hou J, Goldthwaite P, Daniel R, Helzlsouer KJ, Burger PC, Shah KV and Major EO: Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int J Cancer 113: 769-774, 2005.
7. Gordon J, Del Valle L, Croul S, Reiss K, White M and Khalili K: Re: Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories by Rollison et al. Int J Cancer 117: 693-694, 2005.
8. Walker DL, Padgett BL, Zu Rhein GM, Albert AE and Marsh RF: Human papovavirus (JC): induction of brain tumors in hamsters. Science 181: 674-676, 1973.
9. London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M, Wallen WC, Palmer AE, Sever JL, Padgett BL, Walker DL, ZuRhein GM and Ohashi T: Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 201: 1246-1249, 1978.
10. London WT, Houff SA, McKeever PE, Wallen WC, Sever JL, Padgett BL and Walker DL: Viral-induced astrocytomas in squirrel monkeys. In: Polyomaviruses and Human Neurological Diseases. Sever JL and Madden DL (eds.). New York, Alan R Liss Inc., pp. 227-237, 1983.
11. Small JA, Khoury G, Jay G, Howley PM and Scangos GA: Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice. Proc Natl Acad Sci USA 83: 8288-8292, 1986.
12. Franks RR, Rencic A, Gordon J, Zoltick PW, Curtis M, Knobler RL and Khalili K: Formation of undifferentiated mesenteric tumors in transgenic mice expressing human neurotropic polymavirus early protein. Oncogene 12: 2573-2578, 1996.
13. Gordon J, Del Valle L, Otte J and Khalili K: Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice. Oncogene 19: 4840-4846, 2000.
14. Shollar D, Del Valle L, Khalili K, Otte J and Gordon J: JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a transgenic mouse model of malignant peripheral nerve sheath tumors. Oncogene 23: 5459-5467, 2004.
15. Krynska B, Otte J, Franks R, Khalili K and Croul S: Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene 18: 39-46, 1999.
16. Khalili K, Del Valle L, Otte J, Weaver M and Gordon J: Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene 22: 5181-5191, 2003.
17. Stevens MC, Cameron AH, Muir KR, Parkes SE, Reid H and Whitwell H: Descriptive epidemiology of primary central nervous system tumours in children: a population-based study. Clin Oncol (R Coll Radiol) 3: 323-329, 1991.
18. CBTRUS: Statistical report: primary brain tumors in the United States, 1995-1999. Published by the Central Brain Tumor Registry of the United States, 2002.
19. Krynska B, Del Valle L, Gordon J, Otte J, Croul S and Khalili K: Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma. Virology 274: 65-74, 2000.
20. Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A and Khalili K: Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci USA 96: 11519-11524, 1999.
21. Khalili K, Krynska B, Del Valle L, Katsetos CD and Croul S: Medulloblastomas and the human neurotropic polyomavirus JC virus. Lancet 353: 1152-1153, 1999.
22. Lassak A, Del Valle L, Peruzzi F, Wang JY, Enam S, Croul S, Khalili K and Reiss K: Insulin receptor substrate I translocation to the nucleus by the human JC virus T-antigen. J Biol Chem 277: 17231-17238, 2002.
23. Safak M, Barrucco R, Darbinyan A, Okada Y, Nagashima K and Khalili K: Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol 75: 1476-1486, 2001.
24. Darbinyan A, Siddiqui KM, Slonina D, Darbinian N, Amini S, White MK and Khalili K: Role of JC virus agnoprotein in DNA repair. J Virol 78: 8593-8600, 2004.
25. Amini S, Mameli G, Del Valle L, Skowronska A, Reiss K, Gelman BB, White MK, Khalili K and Sawaya BE: p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Mol Cell Biol 25: 8126-8138, 2005.
26. Gallia GL, Safak M and Khalili K: Interaction of the single-stranded DNA-binding protein Puralpha with the human polyomavirus JC virus early protein T-antigen. J Biol Chem 273: 32662-32669, 1998.
27. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE and Givol D: Induction of WAF1/CIP1 by p53-independent pathway. Cancer Res 54: 3391-3395, 1994.
28. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
29. Juven T, Barak Y, Zauberman A, George DL and Oren M: Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8: 3411-3416, 1993.
30. Arias-Lopez C, Lazaro-Trueba I, Kerr P, Lord CJ, Dexter T, Iravani M, Ashworth A and Silva A: p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. EMBO Rep 7: 219-224, 2006.
31. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ and Dessel BH: Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1: 1257-1260, 1971.
32. Theile M and Grabowski G: Mutagenic activity of BKV and JCV in human and other mammalian cells. Arch Virol 113: 221-233, 1990.
33. Lazutka JR, Neel JV, Major EO, Dedonyte V, Mierauskine J, Slapsyte G and Kesminiene A: High titers of antibodies to two human polyomaviruses, JCV and BKV, correlate with increased frequency of chromosomal damage in human lymphocytes. Cancer Lett 109: 177-183, 1996.
34. Neel JV, Major EO, Awa AA, Glover T, Burgess A, Traub R, Curfman B and Satoh C: Hypothesis: "Rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implications for oncopenesis. Proc Natl Acad Sci USA 93: 2690-2695, 1996.
35. Ricciardiello L, Baglioni M, Giovannini C, Pariali M, Cenacchi G, Ripalti A, Landini MP, Sawa H, Nagashima K, Frisque RJ, Goel A, Boland CR, Tognon M, Roda E and Bazzoli F: Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 63: 7256-7262, 2003.
36. Ray FA, Peabody DS, Cooper JL, Cram LS and Kraemer PM: SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 42: 13-31, 1990.
37. Ray FA, Meyne J and Kraemer PM: SV40 T antigen induced chromosomal changes reflect a process that is both clastogenic and aneuploidogenic and is ongoing throughout neoplastic progression of human fibroblasts. Mutat Res 284: 265-273, 1992.
38. Trojanek J, Croul S, Ho T, Wang JY, Darbinyan A, Nowicki M, Valle LD, Skorski T, Khalili K and Reiss K: T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J Cell Physiol 206: 295-300, 2006.
39. Milner J and Medcalf EA: Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65: 765-774, 1991.
40. Blagosklonny MV: p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect. FASEB J 14: 1901-1907, 2000.
41. Vousden KH: Apoptosis. p53 and PUMA: a deadly duo. Science 309: 1685-1685, 2005.
42. Yee KS and Vousden KH: Complicating the complexity of p53. Carcinogenesis 26: 1317-1322, 2005.
43. Krynska B, Gordon J, Otte J, Franks R, Knobler R, DeLuca A, Giordano A and Khalili K: Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein. J Cell Biochem 67: 223-230, 1997.
44. Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, Henning W, Pedeux R, Wang XW, Hofseth LJ, Yang Q, Garfield SH, Sturzbecher HW and Harris CC: p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res 63: 2596-2605, 2003.